Applicant, as named in the Orange Book
Veloxis Pharms Inc
Next listed expiry: Envarsus Xr on 30 Aug 2028. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Envarsus Xr NDA 206406 ยท 3 strengths tacrolimus | 30 Aug 2028 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.